
2205 Pill Green Round - Pill Identifier - Drugs.com
Pill with imprint 2205 is Green, Round and has been identified as Ferrous Sulfate 325 mg. It is supplied by Teva Pharmaceuticals USA.
Pill Finder: 2205 Green Round - Medicine.com
Includes images and details for pill imprint 2205 including shape, color, size, NDC codes and manufacturers.
Pill Identifier - Find Pills by Color, Shape, Imprint, or Picture - WebMD
Use WebMD’s Pill Identifier to find and identify any over-the-counter or prescription drug, pill, or medication by color, shape, or imprint and easily compare pictures of multiple drugs.
Pill Identifier - Quickly Find and ID your Drugs (with pictures)
Use our Pill Identifier tool to instantly match by imprint, shape, color, drug name, or NDC code. Access over 11,500 drug images, updated daily.
2205 Pill Images - Pill Identifier - Drugs.com
Pill Identifier results for "2205". Search by imprint, shape, color or drug name.
Pill Identifier (Pill Finder Wizard) - Pill Identification Tool Using ...
2025年1月24日 · Wizard pill finder tool to help identify pills by tablet imprint codes, shape or drug color. View drug pictures to help identify drugs including prescription, OTC, generic, and brand names.
DailyMed - PEPTO-BISMOL- bismuth subsalicylate tablet, chewable …
2023年10月3日 · Why is DailyMed no longer displaying pill images on the Search Results and Drug Info pages? Due to inconsistencies between the drug labels on DailyMed and the pill images provided by RxImage, we no longer display the RxImage pill images associated with drug labels.
凯复医药创新药KBP-2205片临床试验获得NMPA批准 - Pharmcube
2024年3月1日 · 关于KBP-2205 KBP-2205是凯复医药自主研发的具有全球知识产权的小分子化药,主要临床适应症为晚期恶性实体瘤,包括具有同源重组修复缺陷或存在BRCA基因突变的乳腺癌、卵巢癌、胰腺癌、前列腺癌等。
Keythera Pharmaceuticals' Innovative Drug KBP-2205 Tablets …
2024年3月1日 · KBP-2205 is a small molecule drug with global intellectual property rights, independently discovered by Keythera Pharmaceuticals. Its primary clinical indications are advanced malignant solid tumors, including breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, etc., with homologous recombination repair defects or BRCA gene ...
CNF-2205-靶点_适应症: 精神分裂症-临床_专利_批准
CNF-2205是由深圳市新阳唯康科技有限公司研发的一种小分子药物,目前该药物最高研发阶段为临床阶段不明,用于治疗精神分裂症。